￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Oncology

Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Lumakras, the first KRAS inhibitor, receives accelerated approval from the FDA for the treatment of non-small cell lung cancer - Kanghule

2025-10-19 11:44:20

Check Details
FDA approves Lumakras as the world's first KRAS targeted therapy! How to buy it?

2025-10-19 11:44:20

Check Details
Rybrevant, the first EGFR20ins targeting drug for lung cancer, has been approved for marketing. Is it effective?

2025-10-19 11:44:20

Check Details
How effective is ramucirumab treatment? Are there any side effects

2025-10-19 11:44:20

Check Details
New drug for lung cancer: MET inhibitor Tepotinib Hydrochloride Tablets Tepmetk

2025-10-19 11:44:20

Check Details
What is the function of larotrectinib? Are the side effects obvious

2025-10-19 11:44:20

Check Details
Can larotrectinib be purchased in domestic pharmacies? What is the price

2025-10-19 11:44:20

Check Details
The launch of AMG510 breaks the situation of no cure for KRAS G12C mutant non-small cell lung cancer

2025-10-19 11:44:20

Check Details
MET inhibitor-capmatinib for the treatment of advanced non-small cell lung cancer

2025-10-19 11:44:20

Check Details
What is capmatinib? Is the effect really that good?

2025-10-19 11:44:20

Check Details
Rubitidine combined with irinotecan in the treatment of relapsed small cell lung cancer

2025-10-19 11:44:20

Check Details
Small cell lung cancer is finally looking forward to a new chemotherapy drug - rupitidine

2025-10-19 11:44:20

Check Details
Category
相关知识